REGN
Regeneron Pharmaceuticals Inc
788.00$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.65 | 30.18 | 27.32 | 30.74 | 32.02 | 33.30 | 27.24 | 33.85 | 35.02 | 36.13 | 33.48 | 40.18 | 145.46 | |
| 4.78 | 5.53 | 3.77 | 4.16 | 4.23 | 4.97 | 4.18 | 4.88 | 4.87 | 5.44 | 6.22 | 5.40 | 22.02 | |
| 24.88 | 24.65 | 23.56 | 26.58 | 27.79 | 28.33 | 23.06 | 28.96 | 30.16 | 30.69 | 27.26 | 34.78 | 123.43 | |
| 8.55 | 9.23 | 10.91 | 10.61 | 11.43 | 12.53 | 12.05 | 13.18 | 14.53 | 15.13 | 15.28 | 15.28 | 60.50 | |
| 5.65 | 6.48 | 5.99 | 6.58 | 6.15 | 6.96 | 5.69 | 5.84 | 6.14 | 7.21 | 6.01 | 6.20 | 25.68 | |
| 14.20 | 15.42 | 17.03 | 17.31 | 17.64 | 19.63 | 17.74 | 19.02 | 20.58 | 22.51 | 21.29 | 21.48 | 86.26 | |
| 10.68 | 9.23 | 6.53 | 9.27 | 10.15 | 8.70 | 5.32 | 9.94 | 9.58 | 8.19 | 5.97 | 13.30 | 37.17 | |
| 0.16 | 0.16 | 0.14 | 0.13 | 0.12 | 0.09 | 0.08 | 0.03 | 0.18 | 0.11 | 0.12 | 0.10 | 0.52 | |
| 9.80 | 10.08 | 6.09 | 14.11 | 12.85 | 8.42 | 8.14 | 13.98 | 16.45 | 9.71 | 7.72 | 14.31 | 48.37 | |
| 0.91 | -0.11 | -0.19 | 1.70 | 1.31 | 0.36 | 0.87 | 1.17 | 2.83 | 1.85 | 0.97 | 2.16 | 7.84 | |
| 8.89 | 10.19 | 6.27 | 12.41 | 11.54 | 8.06 | 7.27 | 12.81 | 13.62 | 7.86 | 6.75 | 12.14 | 40.53 | |
| 10.88 | 11.24 | 7.22 | 15.28 | 14.01 | 9.62 | 9.36 | 15.26 | 17.90 | 11.17 | 8.98 | 15.57 | 53.84 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.